Remove Competition Remove Medicine Remove Pharmaceutical products
article thumbnail

EU Urban Wastewater Treatment Directive may compromise EU medicine availability

European Pharmaceutical Review

Based on the new cost estimates, pharmaceutical manufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.

article thumbnail

TOP 10 CHALLENGES IN PHARMACEUTICAL PRODUCT LIFE CYCLE MANAGEMENT

eMediWrite

Understanding a product’s life cycle can assist a company in determining its position in the market relative to rivals and the success or failure of the product. Pharmaceutical firms must deal with various regulatory, linguistic, and counterfeit control needs as a result of global distribution. Technology transfer.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Global comparator data signal “alarm bells” for UK Government, says APBI

pharmaphorum

Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. Despite the UK’s potential as an international life sciences leader, it lags many competitors in a number of key metrics, including access to new medicines and global share of clinical trial recruitment. Access to medicines.

article thumbnail

The Top 10 Clinical Research Companies in the USA

Medico Reach

To bring effective medicines and Innovations in healthcare industry , a Clinical Research Organization or Contract Research Organization (CRO) are a must for the Biotech, Medtech, and pharma industries. Pharmaceutical Product Development (PPD). Founded: 1985 Headquarters: Wilmington, North Carolina Annual Revenue: $65.0M

article thumbnail

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

These events led to the publication of the EU Pharmaceuticals Strategy in 2020, 1 which, in addition to a range of other activities, aims to ensure the regulatory system for human medicines is future?proof To this end, the strategy lays out a timeline for review of the EU’s general legislation on medicines for human use.

article thumbnail

Navigating Pharma Sales Challenges: Tips to Boost Your Sales Performance (Use of AI and Social Media for Effective brand promotion)

Pharmaceutical Representative Training

One of the most difficult parts of introducing a pharmaceutical product is the regulatory environment. Early on in the process, interact with consumers and estimate the possible long-term benefits your product may provide using predictive analytics.

Media 52
article thumbnail

TAS-117 by Taiho Pharmaceutical for Chondrosarcoma: Likelihood of Approval

Pharmaceutical Technology

The drug candidate acts as selective non-ATP competitive inhibitor of AKT. Taiho Pharmaceutical overview Taiho Pharmaceutical (Taiho), a subsidiary of Otsuka Group, develops and markets pharmaceutical products in the field of cancer, immunology, allergy and urology. It is a small molecule administered by orally.